Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 振兴生化股份有限公司属医药生产、火力发电行业.主要经营单采血浆的生产采集、储存和销售;血液收购,血液生物制品及保健康复制品的研究、开发、生产销售;药膏、医用生物材料、医疗器械的开发、生产和销售等;电力生产和销售等.公司主要产品有人血白蛋白、人免疫球蛋白、静脉注射用人免疫球蛋白(PH4)、狂犬病人免疫球蛋白、乙型肝炎人免疫球蛋白、破伤风人免疫球蛋白、田七镇痛膏、麝香追风膏、麝香壮骨膏、消炎镇痛膏、跌伤灵贴膏、医用纱布、电力等。
Main Business 血液制品的研究、开发、生产和销售。
Legal Representative 李昊
Top Executives
董事长：李昊
董事：闫磊,杨莉,叶兰,司文彬,黄晓英,李昊
独立董事：刘俊,董作军,尹军,章金刚,汪文祺
Top 5 Shareholder
Shareholder name Nature Holding Date
共青城胜帮英豪投资合伙企业（有限合伙）流通A股20.98%31/03/2024
哈尔滨同智成科技开发有限公司限售股+流通A股10.97%31/03/2024
深圳市航运健康科技有限公司流通A股4.67%31/03/2024
西藏浙岩投资管理有限公司限售股+流通A股2.02%31/03/2024
横琴广金美好基金管理有限公司－美好海德薇一号私募证券投资基金流通A股1.86%31/03/2024
Company Secretary 赵玉林
Solicitors 北京市嘉源律师事务所
Auditors 大华会计师事务所（特殊普通合伙）
Tel No 0759-2931218
Fax No 0759-2931213
Website --
Email ir@slbiop.com
Company Address
Register: 山西省太原市晋源区长兴南街8号阳光城环球金融中心3004室
Office: 广东省湛江市麻章区东简镇东海岛新丰东路1号
Listing Date 28/06/1996
Shares Capital
Shares Capital: 732,744,273
Total A Share: 732,744,273
Listed A Share: 687,667,255
Non-tradable A Share: 45,077,018
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.838
DPS(RMB)* ¥ 0.200
NBV Per Share(RMB)* ¥ 10.135
Market Capitalization(RMB) 19.839B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.